Such double positivity has been shown previously in 20% (17), 41% (16), and 53% (19) of C4NeF-postive C3G/MPGN patients, although isolated C4NeF has also been reported in these studies. The gene discussed is RAPGEF1; the disease is primary membranoproliferative glomerulonephritis.